2020
Indications and outcomes of superselective neck dissection: A review and analysis of the literature.
Verma A, Chen AY. Indications and outcomes of superselective neck dissection: A review and analysis of the literature. The Laryngoscope 2020, 5: 672-676. PMID: 32864437, PMCID: PMC7444773, DOI: 10.1002/lio2.421.Peer-Reviewed Original Research
2018
The effects of concurrent chemoradiation therapy to the base of tongue in a preclinical model.
Benedict PA, Ruiz R, Verma A, Dion GR, Oh P, Wang B, Ahmed OH, Hiwatashi N, Bing R, Victor K, Hu KS, Johnson A, Branski RC, Amin MR. The effects of concurrent chemoradiation therapy to the base of tongue in a preclinical model. The Laryngoscope 2018, 128: 1783-1790. PMID: 29280493, DOI: 10.1002/lary.27033.Peer-Reviewed Original ResearchOrthognathic Considerations of Vascular Malformations.
Delgado L, Verma A, O TM, Super S. Orthognathic Considerations of Vascular Malformations. Otolaryngologic Clinics Of North America 2018, 51: 225-235. PMID: 29217065, DOI: 10.1016/j.otc.2017.09.016.Peer-Reviewed Original ResearchLaryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort.
Benedict PA, Ruiz R, Yoo M, Verma A, Ahmed OH, Wang B, Dion GR, Voigt A, Merati A, Rosen CA, Amin MR, Branski RC. Laryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort. The Laryngoscope 2018, 128: 138-143. PMID: 28714564, DOI: 10.1002/lary.26742.Peer-Reviewed Original Research
2015
The Safety of Antithrombotic Therapy During In-office Laryngeal Procedures-A Preliminary Study.
Fritz MA, Peng R, Born H, Cerrati EW, Verma A, Wang B, Branski RC, Amin MR. The Safety of Antithrombotic Therapy During In-office Laryngeal Procedures-A Preliminary Study. Journal Of Voice : Official Journal Of The Voice Foundation 2015, 29: 768-71. PMID: 25619470, DOI: 10.1016/j.jvoice.2014.12.007.Peer-Reviewed Original Research
2014
Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: a preliminary study.
Born H, Ruiz R, Verma A, Taliercio S, Achlatis S, Pitman M, Gandonu S, Bing R, Amin MR, Branski RC. Concurrent oral human papilloma virus infection in patients with recurrent respiratory papillomatosis: a preliminary study. The Laryngoscope 2014, 124: 2785-90. PMID: 25059492, DOI: 10.1002/lary.24850.Peer-Reviewed Original ResearchMagnetic resonance imaging of the effortful swallow.
Fritz M, Cerrati E, Fang Y, Verma A, Achlatis S, Lazarus C, Branski RC, Amin M. Magnetic resonance imaging of the effortful swallow. The Annals Of Otology, Rhinology, And Laryngology 2014, 123: 786-90. PMID: 24916396, DOI: 10.1177/0003489414538607.Peer-Reviewed Original ResearchRisk factors for adult-onset recurrent respiratory papillomatosis.
Ruiz R, Achlatis S, Verma A, Born H, Kapadia F, Fang Y, Pitman M, Sulica L, Branski RC, Amin MR. Risk factors for adult-onset recurrent respiratory papillomatosis. The Laryngoscope 2014, 124: 2338-44. PMID: 24764146, DOI: 10.1002/lary.24730.Peer-Reviewed Original Research
2010
Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C
Verma A, DeGrado J, Hittelman AB, Wheeler MA, Kaimakliotis HZ, Weiss RM. Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C. BJU International 2010, 107: 1154-1161. PMID: 20735383, DOI: 10.1111/j.1464-410x.2010.09543.x.Peer-Reviewed Original ResearchConceptsVascular endothelial growth factorVascular endothelial growth factor receptor 2Bladder cancer cellsVEGF receptor 1Bladder of ratsEndothelial growth factorVEGFR-2 mRNAMitomycin CVEGFR-2 proteinCancer cellsSurvivin siRNAVEGF concentrationsMMC concentrationsUrinary vascular endothelial growth factorGrowth factorVEGFR-2 concentrationsGrowth factor receptor 2Superficial bladder cancerTransitional cell carcinomaMMC treatmentEndothelial growth factor receptor 2Factor receptor 2Interleukin-6 mRNAEffective intravesical treatmentLower MMC concentrations1153 EFFECT OF MITOMYCIN C ON LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS RECEPTORS IN BLADDER CANCER CELLS AND IN BLADDERS OF RATS INTRAVESICALLY INSTILLED WITH MITOMYCIN C
Verma A, Wheeler M, DeGrado J, Kaimakliotis H, Hittelman A, Weiss R. 1153 EFFECT OF MITOMYCIN C ON LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS RECEPTORS IN BLADDER CANCER CELLS AND IN BLADDERS OF RATS INTRAVESICALLY INSTILLED WITH MITOMYCIN C. Journal Of Urology 2010, 183: e446-e447. DOI: 10.1016/j.juro.2010.02.652.Peer-Reviewed Original Research436 EFFECT OF SURVIVIN SIRNA AND VEGF SIRNA COMPLEXED IN NANOPARTICLES ON BLADDER CANCER CELLS AND UROTHELIAL TISSUES
Saltzman A, Woodrow K, Wheeler M, Verma A, Saltzman W, Weiss R. 436 EFFECT OF SURVIVIN SIRNA AND VEGF SIRNA COMPLEXED IN NANOPARTICLES ON BLADDER CANCER CELLS AND UROTHELIAL TISSUES. Journal Of Urology 2010, 183: e172-e173. DOI: 10.1016/j.juro.2010.02.507.Peer-Reviewed Original Research